December 21, 2022
The Effect of Aging in Multiple Sclerosis and the Model of Care: Ruth Ann Marrie, MD, PhD, FRCPC
- /
December 13, 2022 The professor of medicine at the University of Manitoba discussed the need to change how multiple sclerosis…
MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.
December 21, 2022
Finding Resources for the MS Community
- /
- /
- /
- /
- /
Use the tools on this page to find resources and providers near you. If you need guidance, see our category guides.…
December 20, 2022
At-Home OTC COVID-19 Diagnostic Tests / Expiration Date information
- /
December 14, 2022 General Information About At-Home OTC COVID-19 Diagnostic Tests This page has information about at-home over-the-counter (OTC) COVID-19…
December 16, 2022
What Is Spasticity? Symptoms, Causes, Diagnosis, and Treatment
- /
By Julie Lynn Marks – Medically Reviewed by Jason Paul Chua, MD, PhD Reviewed: May 12, 2022…
December 16, 2022
EVUSHELD is no longer effective against newer Omicron subvariants
- /
- /
Article provided by: Cherie C Binns RN MSCN As SARS-CoV-2, the virus that causes COVID-19, continues to evolve, monoclonal antibodies are no…
December 6, 2022
Many people complain about winter, but it can be a particularly challenging time for those who live with chronic conditions
- /
Chris Anderson is no stranger to bad winters. He lives in Minnesota — a state that gets, on average, between 35–70…
December 1, 2022
Antidepressant Bupropion Found to Ease Sexual Dysfunction in MS
- /
- /
Dec 2022 Daily treatment with an oral antidepressant called bupropion — marketed as Wellbutrin and Zyban, among others — significantly improved some…
November 28, 2022
Under the microscope: what is the potential of BTK inhibitors (BTKI) ?
- /
- /
- /
information provided by: MS Society UK Bruton’s tyrosine kinase (BTK) inhibitors are an emerging type of disease modifying therapy (DMT)…
November 26, 2022
The MS wealth death gap. Rich people with MS are 16.6% more likely to be alive after 30 years compared with poor people with MS [according to this observational study in France].
- /
Abstract Background: The effects of socio-economic status on mortality in patients with multiple sclerosis is not well known. The objective…
November 26, 2022
FDA requests additional information, extends goal date for application of MS treatment
- /
November 18, 2022 The FDA has extended the Prescription Drug User Fee Act goal date to Dec. 28, for TG…
